High energy formula that stimulates thermogenesis designed for all over weight reduction and body slimming.
Adipotrim is recommended if weight loss has slowed, hit a plateau, or appetite is increased (or esp. if the other slimming options available are no longer serving you well).
(NOTE-I've been testing (along with a handful of volunteers) & we've noticed a higher level of reduction in appetite & food consumption norms) ☆BE ADVISED☆it is POTENT (more so than other options available on the site) & in my opinion, if you find this to be the case please consider taking with or after food.
Adipotrim XT contains several natural ingredients such as Bitter Orange and Cacao along with Vitamin D, Niacin, Yohimbine & L- Arginine which may work to help suppress appetite, speed up metabolism, and balance hormones to help decrease body fat. Adipotrim XT was designed to help support your weight loss goals and produce noticeable results.
Use: 1 Capsule Once Daily, Pre, or Post Breakfast with at Least 8 Glasses of Water Daily.
These Statements Have Not Been Evaluated by the FDA.
Shelf Life: 24 months
Suitable Age: 18 and over
TIPS
☆Refrain from high sugar, salt, and caffeine beverages
☆Intake 8 glasses of water daily (or more)
☆Increase fiber intake (fruits/veggies or supplement)
☆Eat several small meals throughout the day
☆Light to moderate exercise
☆NO ALCOHOL
Adipotrim XT Is An OEM Product Distributed By FaceFab LLC. It Is Not Intended to Diagnose, Treat, Cure or Prevent Any Illness or Disease. Caution: Those who suffer from heart diseases have high blood pressure, pregnant, breastfeeding, or taking any other prescribed/non-prescribed medications can possibly counter-react with the supplement and can experience side effects.
-Increased blood pressure/heart rate &/or insomnia if taken late in the day.
-Altered taste, constipation, and dry mouth are also possible.
Please consult your health care professional prior to starting any weight loss program & also for guidance/dosage amounts dependent on your individual needs if unsure.
